Ranney agreed: "Unfortunately, you will discover groups across the country that continue to get unaware of the ability to get these therapies or just don't have use of them," she stated, noting modern research displaying that Black, Asian and Hispanic people today had been more unlikely than white people today for being prescribed monoclonal antibo